YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs.
Minari R, Valentini S, Madeddu D, Cavazzoni A, La Monica S, Lagrasta CAM, Bertorelli R, De Sanctis V, Fassan P, Azzoni C, Bottarelli L, Frati C, Gnetti L, Facchinetti F, Petronini PG, Alfieri R, Romanel A, Tiseo M.
Minari R, et al. Among authors: valentini s.
JTO Clin Res Rep. 2022 Jan 20;3(2):100278. doi: 10.1016/j.jtocrr.2022.100278. eCollection 2022 Feb.
JTO Clin Res Rep. 2022.
PMID: 35199053
Free PMC article.